Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Baijie Tang"'
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Microcystic adnexal carcinoma (MAC) is a skin cancer with challenges in diagnosis and management. This study was aimed to detect molecular alterations of MAC and guide its pathologic diagnosis and treatment. Methods We performed t
Externí odkaz:
https://doaj.org/article/68348b079d3f441aa3ae0c04a7024868
Autor:
Dandan Dong, Huajiang Lei, Duanya Liu, Hansong Bai, Yue Yang, Baijie Tang, Ke Li, Juan Liu, Gang Xu, Xue Xiao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveAlthough Polymerase-epsilon (POLE)-mutated and mismatch repair (MMR)-deficient endometrial cancers (ECs) are considered as promising candidates for anti-PD-1/PD-L1 therapy, selecting only these patients may exclude other patients who could p
Externí odkaz:
https://doaj.org/article/101b1f125d1e4123b38ca459e69ccd4b
Publikováno v:
Applied Sciences, Vol 12, Iss 11, p 5632 (2022)
Two specimens of low-yield-point steel plate shear walls used for the experimental investigation into different failure modes of the structure were respectively carried out by the horizontal and vertical loading tests in this paper. The results deriv
Externí odkaz:
https://doaj.org/article/7b99bd5fd933486db97347f0e747ff68
Publikováno v:
Iranian Journal of Science and Technology, Transactions of Civil Engineering. 46:3739-3752
Publikováno v:
Magnetic Resonance Materials in Physics, Biology and Medicine.
To analyze the association of apparent diffusion coefficient (ADC) values measured by readout-segmented echo-planar imaging (rs-EPI) using different simultaneous multislice (SMS) acceleration factors and the differentiation of rectal cancer grade.Pat
Autor:
Duanya Liu, Baijie Tang, Ke Li, Hansong Bai, Xue Xiao, Dandan Dong, Yue Yang, Gang Xu, Juan Liu, Huajiang Lei
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectiveAlthough Polymerase-epsilon (POLE)-mutated and mismatch repair (MMR)-deficient endometrial cancers (ECs) are considered as promising candidates for anti-PD-1/PD-L1 therapy, selecting only these patients may exclude other patients who could p